Estimated Conjunctivitis-Related Healthcare Cost Savings With Increased Tralokinumab Use Versus Other Biologics Among Patients With Moderate-Severe Atopic Dermatitis in the United States. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s630, 2025. DOI: 10.25251/ej4zcr36. Disponível em: https://skin.dermsquared.com/skin/article/view/3919. Acesso em: 1 may. 2026.